|
 July 2023
|
|
New Issue of In Focus Explores Sex Differences in Neurological Health Conditions
The latest issue of Women’s Health in Focus at NIH explores issues relevant to neuroscientific research. The feature story focuses on sex differences in neurological conditions involving glia, historically understudied cells in the central and peripheral nervous system. A guest editorial considers the ways that pregnancy, lactation, and caregiving alter the brain.
The “Scientist Spotlight” article features geneticist Guillermina Lozano, Ph.D., Professor and Chair of the Department of Genetics at the University of Texas MD Anderson Cancer Center. Dr. Lozano’s lab studies the p53 tumor suppressor that prevents the formation of cancers in humans.
This issue also features an article on the establishment of the new Office of Autoimmune Disease Research (OADR-ORWH). In 2022, the U.S. Congress directed NIH to establish OADR-ORWH within ORWH. ORWH is working with NIH leadership, other ICOs, researchers, clinicians, patient advocacy groups, and the public to ensure that plans for the new office synergize with other NIH efforts, observe congressional directives, address autoimmune disease research gaps, and serve patients with autoimmune disorders.
Read In Focus
|
 What Are Autoimmune Diseases?
Autoimmune diseases occur when the body’s immune system malfunctions and mistakenly attacks the body’s healthy cells, tissues, and organs. They can affect specific organs or multiple organ systems and may result in poor quality of life, withdrawal from the labor force, and even shortened life expectancy.
Autoimmune diseases include at least 80 acute and chronic illnesses that are often disabling, such as Sjögren’s disease, systemic lupus erythematosus (SLE), antiphospholipid syndrome, rheumatoid arthritis, psoriasis, inflammatory bowel disease (IBD), celiac disease, primary biliary cholangitis, multiple sclerosis, type 1 diabetes, and autoimmune thyroid disease.
Visit the Office of Autoimmune Disease Research webpage to learn more.
|
|
 Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional)
(PAR-23-130)
Application due date: October 5, 2023 (new applications)
November 5, 2023 (renewal/resubmission/revision)
Investigator-Initiated Research in Genomics and Health Equity (R01 Clinical Trial Optional)
(RFA-HG-23-017)
Earliest application submission date: October 8, 2023
Application due date: November 8, 2023
Investigator-Initiated Research in Genomics and Health Equity (R21 Clinical Trial Optional)
(RFA-HG-23-018)
Earliest application submission date: October 8, 2023
Application due date: November 8, 2023
Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)
(PAR-23-131)
Application due date: October 16, 2023 (new applications)
November 16, 2023 (renewal/resubmission/revision)
Native American Research Centers for Health (NARCH) (S06 Clinical Trial Optional)
(PAR-23-166)
Application due date: July 8, 2024
Application due date for AIDS-related Research: August 7, 2024
Notice of Special Interest (NOSI): Administrative Supplements to Promote Research Continuity and Retention of NIH Mentored Career Development (K) Award Recipients and Scholars
(NOT-OD-23-031)
Submission dates vary by awarding ICO.
NOSI: Administrative Supplement for Continuity of Biomedical and Behavioral Research Among First-Time Recipients of NIH Research Project Grant Awards
(NOT-OD-23-032)
Submission dates vary by awarding ICO.
|
|
 Featured Event
Diverse Voices: Intersectional Approaches to
Substance Use and Misuse
The July 2023 session of Diverse Voices: Intersectionality and the Health of Women, titled “Intersectional Approaches to Substance Use and Misuse,” will feature presentations from Drs. Meyer and Meyers-Pantele. Dr. Meyer will discuss integrated solutions to address HIV and substance use disorders (SUDs) among women involved in carceral systems, and Dr. Meyers-Pantele will explore experiences of intersectional stigma among racially and ethnically diverse women who use drugs. Session attendees will learn about (1) ways the "syndemic" of substance use, violence, and HIV overlap and interact among women involved in criminal legal systems; (2) the ongoing development of integrated solutions that prevent HIV and treat SUDs to improve the health of women involved in criminal legal systems; (3) the results of formative qualitative interviews on experiences with stigma, HIV prevention services, and technology use among racially diverse women who use drugs; and (4) how this information will be employed to develop an mHealth intervention to improve HIV prevention service engagement and reduce stigma for this population.
The event will be held virtually on July 27, 2023, from 3:00 p.m. to 4:00 p.m. EDT. Registration is required. Click here for more information and a link to the registration page.
|
Endocrine Disrupting Chemicals and Women's Health Symposium
July 18, 2023
Diverse Voices: Social Determinants and Uptake of Infectious Disease Control Measures
September 28, 2023
59th Meeting of the NIH Advisory Committee on Research on Women's Health
October 18, 2023
Specialized Centers of Research Excellence on Sex Differences (SCORE) 2023 Annual Meeting Keynote Address
November 3, 2023
Building Interdisciplinary Research Careers in Women's Health (BIRCWH) 2023 Annual Meeting
December 5, 2023
View All Events
|
|
|
|
|
